[CLINICAL ASPECTS OF THE STEIN-LEVENTHAL SYNDROME].
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D002996:Clomiphene; D003907:Dexamethasone; D003933:Diagnosis; D005260:Female; D006801:Humans; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D010053:Ovary; D010336:Pathology; D010600:Pharmacology; D010912:Pituitary-Adrenal Function Tests; D011085:Polycystic Ovary Syndrome; D011276:Pregnanediol; D013514:Surgical Procedures, Operative; D014626:Vaginal Smears
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D002996:Clomiphene; D003907:Dexamethasone; D011276:Pregnanediol; D008797:Metyrapone
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ALDOSTERONE ANTAGONISTS; CLOMIPHENE; DEXAMETHASONE; DIAGNOSIS; METYRAPONE; OVARY; PATHOLOGY; PHARMACOLOGY; PITUITARY-ADRENAL FUNCTION TESTS; PREGNANEDIOL; STEIN-LEVENTHAL SYNDROME; SURGERY, OPERATIVE; VAGINAL SMEARS
LE TRAITEMENT DU SYNDROME DE STEIN-LEVENTHAL EST-IL SEULEMENT CHIRURGICAL? R'EFLEXIONS 'A PROPOS D'UNE OBSERVATION.